<table className="table">
  <caption>
    <p>
      Pharmacotherapy for Generalized Anxiety Disorder
    </p>
  </caption>
  <thead>
    <tr>
      <th rowSpan="1" colSpan="1">
        <p>
          Class of Agent
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Specific Agent, Therapeutic Dose
        </p>
      </th>
      <th rowSpan="1" colSpan="1">
        <p>
          Adverse Effects and Notes
        </p>
      </th>
    </tr>
  </thead>
  <tbody>
    <tr className="group_1-1 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          First-line medications: SSRIs and SNRIs
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          As a class: nausea, diarrhea, decreased appetite, restlessness, insomnia, somnolence, impaired sexual function, and hyponatremia
        </p>
      </td>
    </tr>
    <tr className="group_1-2 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          SSRI
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Escitalopram, 10-20 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          QT prolongation
        </p>
        <p>
          10 mg/d is the maximum dose recommended for older adults and those with hepatic impairment
        </p>
      </td>
    </tr>
    <tr className="group_1-3 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          SSRI
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Paroxetine, 20-60 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          More sexual dysfunction, weight gain, and sedation; discontinuation syndrome not uncommon
        </p>
        <p>
          Increased drug interactions, including strong CYP2D6 inhibition
        </p>
      </td>
    </tr>
    <tr className="group_1-4 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          SSRI
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Sertraline, 50-200 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Higher incidence of gastrointestinal distress
        </p>
      </td>
    </tr>
    <tr className="group_1-5 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          SNRI
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Duloxetine, 60-120 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Gastrointestinal distress (less than with venlafaxine)
        </p>
      </td>
    </tr>
    <tr className="group_1-6 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          SNRI
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Venlafaxine extended-release, 75-225 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Higher incidence of gastrointestinal distress; increased blood pressure
        </p>
      </td>
    </tr>
    <tr className="group_1-7 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          Second-line medications
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
        </p>
      </td>
    </tr>
    <tr className="group_1-8 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          Azapirones
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Buspirone, 15-30 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Ineffective for comorbid disorders; dizziness, drowsiness
        </p>
      </td>
    </tr>
    <tr className="group_1-9 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          Benzodiazepines
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Alprazolam, 0.25-1 mg/d; lorazepam, 0.5-2 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          As a class: falls, memory impairment, risk for dependence
        </p>
      </td>
    </tr>
    <tr className="group_1-10 row-even">
      <td rowSpan="1" colSpan="1">
        <p>
          Anticonvulsant
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Pregabalin, 150-600 mg/d
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Sedation, dizziness, peripheral edema
        </p>
        <p>
          Used as an adjuvant to first-line medications
        </p>
        <p>
          Use with caution in patients with renal impairment
        </p>
      </td>
    </tr>
    <tr className="group_1-11 row-odd">
      <td rowSpan="1" colSpan="1">
        <p>
          Antihistamine
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Hydroxyzine, 50-100 mg four times daily
        </p>
      </td>
      <td rowSpan="1" colSpan="1">
        <p>
          Sedation, dry mouth, confusion, and urine retention
        </p>
      </td>
    </tr>
  </tbody>
</table>
